America’s long-held dominance in biotechnology is slowly slipping away. China now conducts more clinical drug trials than the U.S., and its share of global drug-development activity has grown dramatically over the past decade.
America’s long-held dominance in biotechnology is slowly slipping away. China now conducts more clinical drug trials than the U.S., and its share of global drug-development activity has grown dramatically over the past decade.